|
1
|
Yoo G, Park J, Lee SS and Sim HS:
Anisotropic charge Kondo effect in a triple quantum dot. Phys Rev
Lett. 113:2366012014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karki KJ, Widom JR, Seibt J, Moody I,
Lonergan MC, Pullerits T and Marcus AH: Coherent two-dimensional
photocurrent spectroscopy in a PbS quantum dot photocell. Nat
Commun. 5:58692014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blum AS, Moore MH and Ratna BR: Quantum
dot fluorescence as a function of alkyl chain length in aqueous
environments. Langmuir. 24:9194–9197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee H, Kim C, Lee D, Park JH, Searson PC
and Lee KH: Optical coding of fusion genes using multicolor quantum
dots for prostate cancer diagnosis. Int J Nanomed. 12:4397–4407.
2017. View Article : Google Scholar
|
|
5
|
Nigam Joshi P, Agawane S, Athalye MC,
Jadhav V, Sarkar D and Prakash R: Multifunctional inulin tethered
silver-graphene quantum dots nanotheranostic module for pancreatic
cancer therapy. Mater Sci Eng C. 78:1203–1211. 2017. View Article : Google Scholar
|
|
6
|
Li K, Xia C, Wang B, Chen H, Wang T, He Q,
Cao H and Wang Y: Effects of quantum dots on the ROS amount of
liver cancer stem cells. Colloids Surf B Biointerfaces.
155:193–199. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Li Y, Chen Z, Wang T, Gu J, Wu X,
Yin Y, Wang M and Pan Z: The evaluation of colorectal cancer risk
in serum by anti-DESMIN-conjugated CdTe/CdS quantum dots. Clin Lab.
63:579–586. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Y, Zhao Y, Luo H, Liu F and Wu Y:
Construction of EGFR peptide gefitinib/quantum dots long
circulating polymeric liposomes for treatment and detection of
nasopharyngeal carcinoma. Biochem Biophys Res Commun. 490:141–146.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li LN, Xiao T, Yi HM, Zheng Z, Qu JQ,
Huang W, Ye X, Yi H, Lu SS, Li XH, et al: MiR-125b increases
nasopharyngeal carcinoma radioresistance by targetingA20/NF-kappaB
signaling pathway. Mol Cancer Ther. 16:2094–2106. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Su Z, Li G, Liu C, Ren S, Deng T, Zhang S,
Tian Y, Liu Y and Qiu Y: Autophagy inhibition impairs the
epithelial-mesenchymal transition and enhances cisplatin
sensitivity in nasopharyngeal carcinoma. Oncol Lett. 13:4147–4154.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Smith C, Tsang J, Beagley L, Chua D, Lee
V, Li V, Moss DJ, Coman W, Chan KH, Nicholls J, et al: Effective
treatment of metastatic forms of Epstein-Barr virus-associated
nasopharyngeal carcinoma with a novel adenovirus-based adoptive
immunotherapy. Cancer Res. 72:1116–1125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen QY, Tang QN, Tang LQ, Chen WH, Guo
SS, Liu LT, Li CF, Li Y, Liang YJ, Sun XS, et al: Pretreatment
serum amyloid a and c - reactive protein comparing with
Epstein-Barr virus DNA as prognostic indicators in patients with
nasopharyngeal carcinoma: A prospective study. Cancer Res Treat.
Jul 14–2017.(Epub ahead of print). View Article : Google Scholar
|
|
13
|
Wang C, Wang H, Zhang Y, Guo W, Long C,
Wang J, Liu L and Sun X: Berberine inhibits the proliferation of
human nasopharyngeal carcinoma cells via an Epstein-Barr virus
nuclear antigen 1-dependent mechanism. Oncol Rep. 37:2109–2120.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ramayanti O, Juwana H, Verkuijlen SA,
Adham M, Pegtel MD, Greijer AE and Middeldorp JM: Epstein-Barr
virus mRNA profiles and viral DNA methylation status in
nasopharyngeal brushings from nasopharyngeal carcinoma patients
reflect tumor origin. Int J Cancer. 140:149–162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao R, Wang L, Liu Q, Zhang LF, Ye YF, Xie
SH, Du JL, Chen SH, Guo J, Yang MJ, et al: Evaluation of seven
recombinant VCA-IgA ELISA kits for the diagnosis of nasopharyngeal
carcinoma in China: A case-control trial. BMJ Open. 7:e0132112017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dobson R, Topping J and Giovannoni G:
Comparison of two commercial ELISA systems for evaluating
anti-EBNA1 IgG titers. J Med Virol. 85:128–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai YL, Li J, Lu AY, Zheng YM, Zhong WM,
Wang W, Gao JQ, Zeng H, Cheng JR and Tang MZ: Diagnostic
significance of combined detection of Epstein-Barr virus
antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for
nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 15:2001–2006.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang F, Liu Q and Hu CM: Epstein-Barr
virus-encoded LMP1 increases miR-155 expression, which promotes
radioresistance of nasopharyngeal carcinoma via suppressing UBQLN1.
Eur Rev Med Pharmacol Sci. 19:4507–4515. 2015.PubMed/NCBI
|
|
19
|
Luo YL, Chen H, Peng SG, Lin JH and Huang
PY: Assessment of detection assays of Epstein-Barr viral Rta-IgG,
VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical
stages in the diagnosis of nasopharyngeal carcinoma. Zhonghua Yi
Xue Za Zhi. 93:3516–3519. 2013.(In Chinese). PubMed/NCBI
|
|
20
|
Zhang XM, Zhong JM, Tang MZ, Zhang XG,
Liao J, Zheng YM, Deng H and Zeng Y: Comparison of IgA/VCA, IgA/EA,
IgG/EA in immunoenzyme methods and ZEBRA ELISA in early diagnosis
of nasopharyngeal carcinoma. Zhonghua Shi Yan He Lin Chuang Bing Du
Xue Za Zhi. 20:263–265. 2006.(In Chinese). PubMed/NCBI
|
|
21
|
Cai YL, Zheng YM, Cheng JR, Wang W, Zhang
YN, Wang WH, Wu YS, Zhong WM, Li J and Mo YK: Relationship between
clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus
antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA. Nan Fang Yi Ke
Da Xue Xue Bao. 30:509–511. 2010.(In Chinese). PubMed/NCBI
|
